tactivatherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * | ||
Meta Tags
| Title | Tactiva Therapeutics | Innovative Cancer |
| Description | Innovative Engineering of Immune Cells for Potent Cancer Tactiva Therapeutics is an immuno-oncology company specializing in potent cancer immunotherapy using a dual T cell receptor |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.71.233.51 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tactivatherapeutics.com Valuation
|
US$594,154
Last updated: 2023-05-17 09:21:28
tactivatherapeutics.com has Semrush global rank of 17,814,082. tactivatherapeutics.com has an estimated worth of US$ 594,154, based on its estimated Ads revenue. tactivatherapeutics.com receives approximately 68,557 unique visitors each day. Its web server is located in United States, with IP address 198.71.233.51. According to SiteAdvisor, tactivatherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$594,154 |
| Daily Ads Revenue | US$549 |
| Monthly Ads Revenue | US$16,454 |
| Yearly Ads Revenue | US$197,442 |
| Daily Unique Visitors | 4,571 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tactivatherapeutics.com. 600 | A | tactivatherapeutics.com. 600 | IP: 198.71.233.51 |
| tactivatherapeutics.com. 3600 | NS | tactivatherapeutics.com. 3600 | NS Record: ns23.domaincontrol.com. |
| tactivatherapeutics.com. 3600 | NS | tactivatherapeutics.com. 3600 | NS Record: ns24.domaincontrol.com. |
| tactivatherapeutics.com. 3600 | MX | tactivatherapeutics.com. 3600 | MX Record: 0 tactivatherapeutics-com.mail.protection.outlook.com. |
| tactivatherapeutics.com. 3600 | TXT | tactivatherapeutics.com. 3600 | TXT Record: v=verifydomain MS=5579654 |
| tactivatherapeutics.com. 3600 | TXT | tactivatherapeutics.com. 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-17 09:21:28
| Search for: Home The science About News and publications Careers Contact Home The science About News and publications Careers Contact Innovative Engineering of Immune Cells for Potent Cancer Treatment Targeting Cancer in a Specific, Efficient and Durable Manner At Tactiva Therapeutics, we are taking the fight to cancer by developing “Next Generation” adoptive cell therapy (ACT) strategies that deliver lethal hits to cancer cells. Our approach provides robust and sustained immune attack on tumors by infusing large numbers of patients’ own T cells that have been re-programed to recognize, attack and destroy cancer cells. Current ACT approaches in immunotherapy focus primarily on developing anti-tumor CD8 T cell responses while overlooking the critical role of helper CD4 T cells. Tactiva Therapeutics utilizes a unique class of CD4 T cells that not only enhance the anti-tumor function of CD8 T cells , but also exhibit a capacity to directly target the tumor cells. Tactiva Therapeutics has |
tactivatherapeutics.com Whois Information
Domain Name: TACTIVATHERAPEUTICS.COM Registry Domain ID: 2041815749_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-07-12T18:06:11Z Creation Date: 2016-07-11T13:20:57Z Registry Expiry Date: 2022-07-11T13:20:57Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS23.DOMAINCONTROL.COM Name Server: NS24.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-03-18T08:24:56Z <<< |